Older age and ambulatory disability, in addition to other risk factors, were associated with poor outcome in patients with #multiplesclerosis and #COVID19 in the COViMS Registry https://t.co/6TfhJL2KKc #MSCOVID19
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2021 – Jul 2024Where it's discussed
-
X / Twitter45 posts
-
News24 articles
-
Facebook5 posts
-
Blogs3 articles
-
YouTube2 videos
AI synopsis
What people are saying
Discussions express strong agreement, citing data on risk factors such as older age, MS disability, and race, with posts emphasizing the importance of monitoring high-risk groups. The tone is analytical and focused, with examples like the mention that nonambulatory patients face worse outcomes, and references to how treatments and comorbidities affect severity, reflecting deep engagement and perceived high impact.
Most posts acknowledge and support the findings, emphasizing known risk factors like age and disability.
Discussions show strong interest, highlighting points like the impact of different MS treatments and racial factors.
Posts deeply engage by citing specific data points, referencing other research, and analyzing implications.
The discussions suggest the article guides clinical considerations and risk assessments, indicating significant influence.
Abstract in brief
- The study analyzed data from over 1,600 North American patients with multiple sclerosis (MS) who also contracted COVID-19, finding that most had confirmed SARS-CoV-2 infection and varied from mild to severe outcomes, including hospitalization and death.
- Key risk factors linked to more severe COVID-19 outcomes in MS patients included older age and the presence of comorbidities, as well as ambulatory disability, which increased the chances of hospitalization and other severe clinical levels.
- The overall mortality rate among these patients was approximately 3.3%, highlighting the heightened vulnerability of individuals with MS—especially those with disabilities or additional health conditions—to severe COVID-19 complications.]
Top posts
Most liked on X and BlueskyAnne Cross, MD, Amber Salter, MPH, PhD & their North American colleagues published "Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis" March 19 in @JAMANeuro. https://t.co/SoxuTiNgKT
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/1X6iyXT3e9 via @JAMANeuro part of @JAMANetwork
.@JAMANeuro: These data on North American pts w/ #COVID19 infection and #multiplesclerosis showed that both nonambulatory and ambulatory disability were independently related to an increased odds of poor clinical severity levels.#NeuroTwitter #MSAwareness https://t.co/XBCuYwfDI0 https://t.co/BQjzPVaXsE
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - PubMed https://t.co/yHUoBXSG8C
Risk Factors Associated With #Covid19 in #MS patients: 1- high disability, 2-age, 3-Black race, 4-cardiovascular comorbidities and 5-recent GCT https://t.co/RBqIXoUNtd
All mentions
Increased COVID-19 Risk in Multiple Sclerosis Patients
Prof. Simon Faissner presents a detailed analysis of the heightened risk of SARS-CoV-2 infection in patients with multiple sclerosis. This discussion is based on a North American registry study that highlights key…
Therapeutic Strategies in Multiple Sclerosis: DISCOMS Study Insights
In this episode, Prof. Simon Faissner presents the DISCOMS study findings, which examine the risk of new disease activity in multiple sclerosis patients who either continue or discontinue their disease-modifying…
RT @drbarrysinger: @AaronBosterMD #COVID19 risks for people living with #MS on treatment is a concern. Some data suggests B-cell depleting…
@AaronBosterMD #COVID19 risks for people living with #MS on treatment is a concern. Some data suggests B-cell depleting therapy may pose a higher risk of severe COVID-19 while interferon therapy may be safer. https://t.co/L2F9V3RNbi https://t.co/c1RNjAOOh9 Thoughts? @myelinMD @DrJim4MS #MSforum
RT @ms_cme: 5) MS disability is independently assoc'd with worse clinical severity including death from COVID-19. Other risk factors for po…
5) MS disability is independently assoc'd with worse clinical severity including death from COVID-19. Other risk factors for poor outcomes include black race, cardiovascular comorbidities, and recent treatment with steroids. #GetVaccinatedASAP doi: 10.1001/jamaneurol.2021.0688 https://t.co/3agk0QYq8B
Older age and ambulatory disability, in addition to other risk factors, were associated with poor outcome in patients with #multiplesclerosis and #COVID19 in the COViMS Registry https://t.co/BgZB6ndfgY #MSCOVID19
COViMS Registry data helped researchers quickly identify the risk factors for worse #COVID-19 clinical severity or death in patients with #multiplesclerosis, the knowledge that could help clinicians identify patients requiring more monitoring. https://t.co/wGJLuZfbSi
Pubmed: Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/1ze37MJQth
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - JAMA Neurology via BrainSights for iOS https://t.co/MAlgRTFY4Z
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - JAMA Neurology Jour. via BrainSights for iOS https://t.co/MAlgRTFY4Z
RT @WashU_MSCenter: Outcomes and Risk Factors Associated With #SARSCoV2 #Infection in a North American Registry of Patients With #Multiple…
Outcomes and Risk Factors Associated With #SARSCoV2 #Infection in a North American Registry of Patients With #MultipleSclerosis @AnneHCross1 @BeboBruce @NMSSMI @WashUNeurology @WUSTLmed @JAMANeuro https://t.co/75O0mfTJCc
Outcomes and risk factors associated with SARS-CoV-2 Infection in a North American registry of patients with multiple sclerosis https://t.co/lzZsstH0iq
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis | Demyelinating Disorders | JAMA Neurology | JAMA Network
Which factors predict worse COVID-19 outcomes in patients with MS? https://t.co/U1lHv0oe5s Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/HVu9JusGih
Which factors predict worse COVID-19 outcomes in patients with MS? https://t.co/U1lHv0oe5s Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/gGASyP3bcS
RT @NeurologyToday: .@JAMANeuro: These data on North American pts w/ #COVID19 infection and #multiplesclerosis showed that both nonambulato…
RT @NeurologyToday: .@JAMANeuro: These data on North American pts w/ #COVID19 infection and #multiplesclerosis showed that both nonambulato…
.@JAMANeuro: These data on North American pts w/ #COVID19 infection and #multiplesclerosis showed that both nonambulatory and ambulatory disability were independently related to an increased odds of poor clinical severity levels.#NeuroTwitter #MSAwareness https://t.co/XBCuYwfDI0 https://t.co/BQjzPVaXsE
"Identification of risk factors key to "high risk" MS and #COVID19 patients - those who may require intense treatment and monitoring" #multiplesclerosis #SARSCoV2 @JAMANeuro https://t.co/FRSGUWVQdf via @JAMANeuro part of @JAMANetwork
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - PubMed https://t.co/sj0zhv5BkX
RT @WashUNeurology: Anne Cross, MD, Amber Salter, MPH, PhD & their North American colleagues published "Outcomes and Risk Factors Associate…
RT @WashUNeurology: Anne Cross, MD, Amber Salter, MPH, PhD & their North American colleagues published "Outcomes and Risk Factors Associate…
https://t.co/n4v3eTnhNN
Anne Cross, MD, Amber Salter, MPH, PhD & their North American colleagues published "Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis" March 19 in @JAMANeuro. https://t.co/SoxuTiNgKT
Association of age and race with outcome of COVID-19 in people with multiple sclerosis. https://t.co/6FE04sweQw https://t.co/ED18PTtkkd
https://t.co/Hz4oxlLyaK
In this registry-based cross-sectional study of 1626 North American patients with MS and COVID-19 infection was independently associated with increased odds of poor clinical severity levels after adjusting for other risk factors. https://t.co/SdT3PJEret
Enlace al artículo completo
Check out this study on #COVID19 outcomes and risk factors in patients with multiple sclerosis (MS) @JAMANeuro https://t.co/ITRjN07BL0
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - JAMA Neurology via BrainSights for iOS https://t.co/MAlgRTFY4Z
RT @monamarwan: SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/1X6iyXT3e9 via @JAMANeur…
RT @pamuca84: Risk Factors Associated With #Covid19 in #MS patients: 1- high disability, 2-age, 3-Black race, 4-cardiovascular comorbiditi…
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/1X6iyXT3e9 via @JAMANeuro part of @JAMANetwork
RT @pamuca84: Risk Factors Associated With #Covid19 in #MS patients: 1- high disability, 2-age, 3-Black race, 4-cardiovascular comorbiditi…
Risk Factors Associated With #Covid19 in #MS patients: 1- high disability, 2-age, 3-Black race, 4-cardiovascular comorbidities and 5-recent GCT https://t.co/RBqIXoUNtd
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis - PubMed https://t.co/yHUoBXSG8C
https://t.co/MlLz80PJ2O Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis 1626名の患者の内ほとんどが検査陽性SARS-CoV-2感染者(1345名[82.7%])、女性(1202名[74.0%])、再発寛解型MS(1255名[80.4%])。
RT @aussiecoley: SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/qAHrzVVR3u via @JAMANeu…
RT @aussiecoley: SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/qAHrzVVR3u via @JAMANeu…
SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/qAHrzVVR3u via @JAMANeuro part of @JAMANetwork
In dieser Register-basierten Querschnittsstudie von 1626 nordamerikanischen Patienten mit MS und COVID-19-Infektion war eine Gangstörung ein Hinweis auf einen schlechteren klinischen Verlauf. https://t.co/Auoqaj6qjO
RT @JAMANeuro: Older age and ambulatory disability, in addition to other risk factors, were associated with poor outcome in patients with #…
RT @JAMANeuro: Older age and ambulatory disability, in addition to other risk factors, were associated with poor outcome in patients with #…
Older age and ambulatory disability, in addition to other risk factors, were associated with poor outcome in patients with #multiplesclerosis and #COVID19 in the COViMS Registry https://t.co/6TfhJL2KKc #MSCOVID19
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis https://t.co/zejsfhtFs7